Quantum Biopharma Licensee Unbuzzd Wellness to Advance Clinically Validated Alcohol Metabolism Accelerant After Appointing Zappy as CEO
TORONTO, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (FRA: 0K91) (“ Quantum BioPharma ”), today announced its licensee – Unbuzzd Wellness Inc. (the " Company " or " Unbuzzd "), the company behind unbuzzd™ (“ unbuzzd ”) — the scientifically-proven and game-changing beverage proven to acceler…
Short extract only — this publisher licenses its text. Read the full release at the source.
More from Commercial newswire
- Inagene launches GLP-1 Insights Program combining genetic insights with registered dietitian support to help Canadians understand their genetic response to weight management and diabetes medications
- Grand Opening of Eight New Co-op Homes in Digby on former school site
- Building Canada Strong must include the Métis Nation
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,400+ feeds — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →